Viewing nowPimasol 60mg Tablets (Pimasartan Potassium Trihydrate)
Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 202501619 · Approved 2025.06.30 · Insurance code 663608980
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure remains consistently high, putting strain on the heart and blood vessels. This medication is used to control essential hypertension and stabilize blood pressure.
Essential hypertension Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks ~ 12 weeks. Elderly patients No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, an initial dose of 30 mg of this medicine once daily is recommended. (Refer to Precautions for Use, 9. Administration to Elderly Patients.) Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment at 30 milligrams once daily and do not exceed 60 milligrams daily. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this medicine to patients with moderate to severe hepatic impairment (refer to Precautions for Use, 2. Patients Who Must Not Take This Medicine and 10. Administration to Patients with Hepatic Impairment). Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (Refer to Precautions for Use, 3. Patients Who Must Use This Medicine with Caution.)
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, it should be stopped immediately. Patients with allergies to any components of this medication, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with moderate to severe liver impairment, and patients with bile duct obstruction should not use this medication. Additionally, diabetic patients with certain kidney function impairments and patients with specific genetic lactose intolerance should not take this medication. Patients with reduced blood volume or salt levels may experience hypotension; thus, they should be closely monitored when starting treatment or increasing doses. Patients with impaired kidney function, renal artery hypertension, aortic stenosis, or mitral valve stenosis should also be cautiously administered this medication, and those with a history of allergies should exercise caution as well. While taking this medication, various side effects such as headache, dizziness, dyspepsia, muscle pain, skin rash, and others may occur, so it is important to consult a healthcare professional if abnormal symptoms arise. Since hypotension or electrolyte imbalances may occur, patients taking diuretics or on dietary salt restrictions should correct their condition and gradually adjust their doses before taking this medication. Due to the risk of hyperkalemia, patients with heart failure or kidney disorders should have their potassium levels checked regularly. When combined with other antihypertensives, certain diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., there may be an increased risk of side effects due to drug interactions, so caution is advised. Use during pregnancy can pose serious risks to the fetus; hence, if pregnancy is suspected or confirmed, it should be stopped immediately, and a doctor should be consulted. Breastfeeding women are advised to discontinue breastfeeding or the medication as this drug may be secreted in breast milk. The safety and efficacy of this medication in individuals under 18 years of age have not been established, so it is advisable not to use it. Individuals aged 65 and older may be more sensitive to medications, but generally, dose adjustments are not required, although caution is advised. Patients with moderate to severe liver impairment should not take this medication, as it can result in abnormally high concentrations of the drug, leading to risk. In cases of overdose, hypotension or cardiac abnormalities may occur, and immediate treatment is required if symptoms appear. This medication should be kept out of reach of children, and transferring it to another container can pose a risk of quality degradation or accidents.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; thus, it should be stored in a container that does not allow light to pass through. Additionally, it should be kept at room temperature between 1°C and 30°C. Storing it this way helps maintain the drug's effectiveness and safety.
Yellow, oval-shaped, film-coated tablets with a division line on one side.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.